| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |